Literature DB >> 20435575

Ischemic stroke during cisplatin-based chemotherapy for testicular germ cell tumor: case report and review of the literature.

I Meattini1, V Scotti, F Pescini, L Livi, S Sulprizio, V Palumbo, C Sarti, G Biti.   

Abstract

Testicular germ-cell tumors are the most common solid tumor in young men, with an incidence peak between the ages of 20 and 35 years. Even if rare, arterial thromboembolism is a serious and possible complication during cisplatin-based chemotherapy in young patients. The strong association between rapid treatment and favorable outcome is well known. Oncologists need to recognize the symptoms and to alert a stroke unit as soon as possible. We report the management of a young patient affected by non seminomatous testicular neoplasm without cardiovascular risk factors who developed an ischemic stroke during cisplatin-based treatment. We also review the relevant literature.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20435575     DOI: 10.1179/joc.2010.22.2.134

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  3 in total

1.  Cranial irradiation increases risk of stroke in pediatric brain tumor survivors.

Authors:  Cynthia J Campen; Sarah M Kranick; Scott E Kasner; Sudha K Kessler; Robert A Zimmerman; Robert Lustig; Peter C Phillips; Phillip B Storm; Sabrina E Smith; Rebecca Ichord; Michael J Fisher
Journal:  Stroke       Date:  2012-09-11       Impact factor: 7.914

Review 2.  Vascular Toxicities of Cancer Therapies: The Old and the New--An Evolving Avenue.

Authors:  Joerg Herrmann; Eric H Yang; Cezar A Iliescu; Mehmet Cilingiroglu; Konstantinos Charitakis; Abdul Hakeem; Konstantinos Toutouzas; Massoud A Leesar; Cindy L Grines; Konstantinos Marmagkiolis
Journal:  Circulation       Date:  2016-03-29       Impact factor: 29.690

3.  Unusually Located Stroke After Chemotherapy in Testicular Germ Cell Tumors.

Authors:  Braulio Alexander Martinez; Edgar Patricio Correa
Journal:  J Investig Med High Impact Case Rep       Date:  2015-06-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.